Internal Medicine, Medical Oncology · Dallas, TX
NPI
1396184354
Since 2013
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
2201 Inwood Road 3rd Floor Nc3.500
Dallas, TX, 75390
Phone (214) 648-4180
Groups this clinician bills Medicare through
Medicare paid, 2024
$35K
321 services
Medicare patients, 2024
99
Average age 71
Drug cost, 2024
$1.5M
719 prescriptions
Company payments, 2025
$868
From 8 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by David Hsieh was code 99215 (office e&m - established), 188 times for 69 patients. In total David Hsieh billed 321 services in 7 codes, and Medicare paid $35K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-08-26.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Facility | 188 | 69 | $107.59 | $20K |
| 99215 Office E&M - Established | Office | 80 | 43 | $110.45 | $8,836 |
| 99205 Office E&M - New | Facility | 31 | 31 | $137.64 | $4,267 |
By year: 2022 $51K for 1,289 services; 2023 $34K for 321 services; 2024 $35K for 321 services.
Medicare prescription drug claims, 2024
In 2024, the drug David Hsieh prescribed most often to Medicare patients was Prochlorperazine Maleate, with 54 prescriptions and refills. In total David Hsieh wrote 719 Medicare prescriptions that cost $1.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prochlorperazine Maleate Generic | 54 | 54 | 40 | $570 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 53 | 53 | 25 | $1,208 |
| Lenvima Lenvatinib Mesylate | 51 | 51 | 15 | $1.2M |
| Ondansetron Hcl Generic | 50 | 53 | 33 | $444 |
| Dexamethasone Generic | 39 | 43 | 27 | $488 |
| Eliquis Apixaban | 33 | 35 | 11 | $20K |
| Morphine Sulfate Er Morphine Sulfate | 31 | 31 | Under 11 | $812 |
| Prednisone Generic | 25 | 25 | 12 | $88.6 |
| Levothyroxine Sodium Generic | 24 | 68 | Under 11 | $217 |
| Oxycodone Hcl Generic | 23 | 23 | Under 11 | $402 |
| Creon Lipase/Protease/Amylase | 20 | 26 | Under 11 | $47K |
| Lactulose Generic | 19 | 31 | 12 | $490 |
| Potassium Chloride Generic | 18 | 24 | Under 11 | $268 |
| Loperamide Loperamide Hcl | 15 | 16 | 13 | $218 |
| Dronabinol Generic | 14 | 14 | Under 11 | $2,706 |
Brand drugs: 173 claims; generic drugs: 546 claims; opioid claims: 124.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid David Hsieh $868 ($868 in general payments such as food, travel and fees) from 8 companies. The largest payer was BeiGene, Ltd. with $693.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.